HUTCHMED (China) Ltd (NASDAQ:HCM)
| 14.22 Delayed Data As of Mar 23 |  -0.39 / -2.67%Today’s Change | 7.39 Today|||52-Week Range 21.44 | -3.79% Year-to-Date |
Latest HCM News | Press Releases
No recent news for HUTCHMED (China) Ltd.
Today’s Trading
| Previous close | 14.59 |
| Today’s open | 14.45 |
| Day’s range | 13.72 - 14.45 |
| Volume | 276,962 |
| Average volume (3 months) | 484,866 |
| Market cap | $2.3B |
Data as of 3:59pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -73.46% |
| Earnings growth (this year) | +61.02% |
| Earnings growth (next 5 years) | -84.49% |
| Revenue growth (last year) | +19.73% |
| P/E ratio | NM |
| Price/Sales | 5.87 |
| Price/Book | 3.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GLPGGalapagos NV | +0.26 | +0.70% |
| ---- | ||
| SAGESAGE Therapeutics In... | +0.42 | +1.00% |
| IZQVFIndivior PLC | -0.41 | -2.33% |
Data as of 4:00pm ET, 03/23/2023
Financials
| Last reporting date | June 1, 2022 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $426.4M |
| Annual profit (last year) | -$360.8M |
| Net profit margin | -84.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
